|Return to: Biotechnology News|
Europe Platelet Rich Plasma Market to Register 8.30% CAGR till 2022 as P-PRP Gains Dominant Share
Platelet rich plasma (PRP) is a blood plasma product in which concentration of platelets is elevated four to eight times than normal blood platelet concentration. PRP is also called platelet rich gel, platelet enriched plasma and platelet enriched gel. PRP is an effective treatment to treat various diseases such as orthopedic diseases, sports injuries, neurological diseases and cardiothoracic diseases. In addition, PRP therapy has an extensive application in cosmetic industry. This report studies the current scenario as well as future market potential for PRP in Europe.
View exclusive Global strategic Business report of Platelet Rich Plasma Market at: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=4761
The market overview section of the report comprises qualitative analysis of the overall PRP market considering the factors determining the market dynamics such as drivers, restraints and opportunities, along with Porter’s five force analysis and market attractiveness analysis. In addition, various analyses such as event impact analysis, regulatory scenario and value chain analysis has also been provided. Event impact analysis encompasses major events occurred in past decade and are expected to occur during the forecast period and are likely to affect the market dynamics positively or negatively. Value chain analysis includes the study of major steps involved in the PRP preparation and distribution. Regulatory scenario includes the study of different regulatory norms and procedures that regulate the approval and commercialization of PRP devices and products.
The Europe PRP market has been segmented on the basis of types, origins and applications. On the basis of types, the Europe PRP market is categorized as pure-PRP (P-PRP), leukocyte-rich PRP (L-PRP) and pure PRF/leukocyte-rich PRF (L-PRF). Moreover, on the basis of origin, the PRP market has been segmented into autologous, homologous and allogenic PRP. Furthermore, on the basis of application, the Europe PRP market has been classified as neurosurgery, cosmetic surgery, orthopedic surgery, general surgery and others (cardiothoracic surgery, urology, periodontal surgery and oral and maxillofacial surgery). The market for these types, origins and applications has been extensively analyzed on the basis of factors such as usage pattern, sales revenue, geographic presence and technological developments. The market size and forecast in terms of revenue (USD million) for each of these segments have been provided for the period 2012 to 2022, considering 2013 as the base year. The report also provides compounded annual growth rate (CAGR) for each segment for the forecast period 2014 to 2022.
Geographically, the Europe market has been classified into U.K., Germany, France, Italy, Spain, and others. The market size and forecast for each region has been provided for the period 2012 to 2022, in terms of origin, types and applications, along with the CAGR (%) for the forecast period 2014 to 2022.
The report also provides a section on the competitive landscape, wherein the market share analysis of leading players in the Europe PRP market, in terms of percentage share in 2013 has been discussed. Moreover, the market share analysis of key players in Europe has also been provided in the report. A list of recommendations has also been included for new entrants as well as existing market players to help them establish a strong presence in the market and increase their market share. The report concludes with the profiles of major players in the Europe PRP market such as Arthrex, Inc., Biomet, Inc., DePuy Synthes, Inc., Harvest Technologies Corp., Regen Lab SA, and Stryker Corporation. The major market players are evaluated on various parameters such as company overview, financial overview, product portfolio, business strategies, and recent developments.
Read the Present Market Status of Platelet Rich Plasma at: http://www.transparencymarketresearch.com/europe-platelet-rich-plasma-market.html
US Office Contact
90 State Street, Suite 700
Albany, NY 12207
USA - Canada Toll Free: 866-552-3453
Website: http://www.transparencymarketresearch. ...
News Release: Europe Platelet Rich Plasma Market to Register 8.30% CAGR till 2022 as P-PRP Gains Dominant Share
Submitted on: January 02, 2017 01:23:03 PM
Submitted by: Harry Walter
On behalf of: www.transparencymarketresearch.com/europe-platelet-rich-plasma-market.html